Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cellectis Nom. | 2 | 0 | 2 | 0 | €1.70 | €2.38 | 39.870% |
| ImmunityBio Inc. | 2 | 0 | 0 | 0 | €6.11 | €10.00 | 63.773% |
| Astellas Pharma Inc. | 2 | 0 | 1 | 0 | €9.38 | €16.00 | 70.648% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €6.45 | €8.75 | 35.659% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €41.00 | €50.00 | 21.951% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €146.40 | €165.00 | 12.705% |
| Puma Biotechnology Inc. | 2 | 0 | 1 | 0 | €3.01 | €10.00 | 231.785% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €172.95 | - | - |
| Dynavax Technologies Corp | 2 | 0 | 0 | 0 | €10.33 | €26.95 | 161.014% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €74.88 | €100.00 | 33.547% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €76.00 | €80.00 | 5.263% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.52 | - | - |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.08 | €11.00 | 80.981% |
| Novartis AG ADR | 2 | 0 | 1 | 0 | €99.60 | €110.78 | 11.229% |
| Bavarian Nordic A/S | 2 | 0 | 2 | 0 | €25.03 | €31.73 | 26.748% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.05 | - | - |
| Allscripts Healthcare | 2 | 0 | 1 | 0 | €8.70 | €11.95 | 37.374% |
| Stratec SE | 2 | 0 | 0 | 0 | €45.15 | - | - |
| Aurinia Pharmaceuticals Inc. | 1 | 1 | 1 | 0 | €5.16 | €8.75 | 69.442% |
| Steris Corp. | 1 | 0 | 0 | 0 | €204.00 | - | - |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €21.20 | - | - |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.68 | €10.00 | 171.739% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.61 | €3.00 | 390.196% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €19.60 | - | - |